[HTML][HTML] Pharmacotherapy for obesity: moving towards efficacy improvement

W Coutinho, B Halpern - Diabetology & Metabolic Syndrome, 2024 - Springer
Obesity is a chronic, recurring, progressive disease and a major public health problem
associated with several other diseases that lead to disability, morbidity, and mortality. The …

[HTML][HTML] Pharmacotherapy for obesity: moving towards efficacy improvement

W Coutinho, B Halpern - Diabetology & …, 2024 - dmsjournal.biomedcentral.com
Obesity is a chronic, recurring, progressive disease and a major public health problem
associated with several other diseases that lead to disability, morbidity, and mortality. The …

Pharmacotherapy for obesity: moving towards efficacy improvement

W Coutinho, B Halpern - Diabetology & Metabolic Syndrome, 2024 - search.proquest.com
Obesity is a chronic, recurring, progressive disease and a major public health problem
associated with several other diseases that lead to disability, morbidity, and mortality. The …

Pharmacotherapy for obesity: moving towards efficacy improvement.

W Coutinho, B Halpern - Diabetology & Metabolic Syndrome, 2024 - search.ebscohost.com
Obesity is a chronic, recurring, progressive disease and a major public health problem
associated with several other diseases that lead to disability, morbidity, and mortality. The …

Pharmacotherapy for obesity: moving towards efficacy improvement.

W Coutinho, B Halpern - Diabetology & Metabolic Syndrome, 2024 - go.gale.com
Obesity is a chronic, recurring, progressive disease and a major public health problem
associated with several other diseases that lead to disability, morbidity, and mortality. The …

Pharmacotherapy for obesity: moving towards efficacy improvement

W Coutinho, B Halpern - Diabetology & metabolic …, 2024 - pubmed.ncbi.nlm.nih.gov
Obesity is a chronic, recurring, progressive disease and a major public health problem
associated with several other diseases that lead to disability, morbidity, and mortality. The …

Pharmacotherapy for obesity: moving towards efficacy improvement

W Coutinho, B Halpern - Diabetology & Metabolic Syndrome, 2024 - europepmc.org
Obesity is a chronic, recurring, progressive disease and a major public health problem
associated with several other diseases that lead to disability, morbidity, and mortality. The …

[HTML][HTML] Pharmacotherapy for obesity: moving towards efficacy improvement

W Coutinho, B Halpern - Diabetology & Metabolic Syndrome, 2024 - ncbi.nlm.nih.gov
Obesity is a chronic, recurring, progressive disease and a major public health problem
associated with several other diseases that lead to disability, morbidity, and mortality. The …

[PDF][PDF] Pharmacotherapy for obesity: moving towards efficacy improvement

W Coutinho, B Halpern - 2023 - dmsjournal.biomedcentral.com
Obesity is a chronic, recurring, progressive disease and a major public health problem
associated with several other diseases that lead to disability, morbidity, and mortality. The …

Pharmacotherapy for obesity: moving towards efficacy improvement.

W Coutinho, B Halpern - Diabetology & Metabolic Syndrome, 2024 - europepmc.org
Obesity is a chronic, recurring, progressive disease and a major public health problem
associated with several other diseases that lead to disability, morbidity, and mortality. The …